(PAH3) Porsche Automobil Holding SE - Overview
Stock: Holding, Sports Cars, Investment, SUV
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.41% |
| Yield on Cost 5y | 3.88% |
| Yield CAGR 5y | -3.58% |
| Payout Consistency | 89.6% |
| Payout Ratio | 20.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.9% |
| Relative Tail Risk | -4.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -4.48 |
| Character TTM | |
|---|---|
| Beta | 0.162 |
| Beta Downside | 0.255 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.74% |
| CAGR/Max DD | -0.22 |
Description: PAH3 Porsche Automobil Holding SE January 06, 2026
Porsche Automobil Holding SE (PAH3) is a German holding company that, through its subsidiaries, controls a portfolio of premium automotive brands-including Volkswagen, Audi, SEAT, ŠKODA, Bentley, Lamborghini and Porsche. It operates two reporting segments: Core Investments, which primarily reflects its stake in Volkswagen AG, and Portfolio Investments, focused on broader mobility and industrial-technology assets. The firm was renamed from Dr. Ing. h.c. F. Porsche AG in November 2007 and is headquartered in Stuttgart.
Key data points as of FY 2023: the holding’s indirect exposure to Volkswagen generated €250 billion in revenue for the group, with an EBIT margin of roughly 8 % after accounting for the automotive sector’s shift toward electric vehicles (EVs). The EV market is expected to grow at a CAGR of 22 % through 2030, putting pressure on legacy brands to accelerate electrification while navigating EU emissions standards and semiconductor supply constraints. Additionally, Porsche SE’s cash-flow generation remains robust, delivering €5 billion in free cash flow, which supports dividend payouts and potential strategic acquisitions.
For a deeper quantitative dive, the ValueRay platform provides up-to-date valuation metrics and scenario analysis for PAH3.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -21.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.77 > 1.0 |
| NWC/Revenue: -9.61% < 20% (prev 42.85%; Δ -52.46% < -1%) |
| CFO/TA 0.02 > 3% & CFO 707.0m > Net Income -21.28b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 14.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (306.2m) vs 12m ago 0.0% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: -40.00% > 50% (prev 8.45%; Δ -48.45% > 0%) |
| Interest Coverage Ratio: -61.22 > 6 (EBITDA TTM -21.51b / Interest Expense TTM 360.0m) |
Altman Z'' 4.43
| A: 0.05 (Total Current Assets 2.23b - Total Current Liabilities 156.0m) / Total Assets 42.85b |
| B: 0.71 (Retained Earnings 30.37b / Total Assets 42.85b) |
| C: -0.41 (EBIT TTM -22.04b / Avg Total Assets 53.88b) |
| D: 4.34 (Book Value of Equity 30.85b / Total Liabilities 7.12b) |
| Altman-Z'' Score: 4.43 = AA |
What is the price of PAH3 shares?
Over the past week, the price has changed by -2.70%, over one month by -9.54%, over three months by +1.09% and over the past year by -0.54%.
Is PAH3 a buy, sell or hold?
What are the forecasts/targets for the PAH3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.5 | 14.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 34.7 | -1.7% |
PAH3 Fundamental Data Overview February 03, 2026
P/E Forward = 3.2733
P/S = 1.1957
P/B = 0.3109
Revenue TTM = -21.55b EUR
EBIT TTM = -22.04b EUR
EBITDA TTM = -21.51b EUR
Long Term Debt = 6.84b EUR (from longTermDebt, last quarter)
Short Term Debt = 124.0m EUR (from shortTermDebt, last quarter)
Debt = 6.97b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.70b EUR (from netDebt column, last quarter)
Enterprise Value = 16.38b EUR (10.68b + Debt 6.97b - CCE 1.26b)
Interest Coverage Ratio = -61.22 (Ebit TTM -22.04b / Interest Expense TTM 360.0m)
EV/FCF = 23.18x (Enterprise Value 16.38b / FCF TTM 707.0m)
FCF Yield = 4.31% (FCF TTM 707.0m / Enterprise Value 16.38b)
WARNING: Negative Revenue TTM = -21.55b
FCF Margin = -3.28% (FCF TTM 707.0m / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Net Margin = 98.76% (Net Income TTM -21.28b / Revenue TTM -21.55b)
WARNING: Negative Revenue TTM = -21.55b
Gross Margin = unknown ((Revenue TTM -21.55b - Cost of Revenue TTM 24.0m) / Revenue TTM)
Tobins Q-Ratio = 0.38 (Enterprise Value 16.38b / Total Assets 42.85b)
Interest Expense / Debt = 1.02% (Interest Expense 71.0m / Debt 6.97b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -16.53b (EBIT -22.04b * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 14.28 (Total Current Assets 2.23b / Total Current Liabilities 156.0m)
Debt / Equity = 0.20 (Debt 6.97b / totalStockholderEquity, last quarter 35.73b)
Debt / EBITDA = -0.27 (negative EBITDA) (Net Debt 5.70b / EBITDA -21.51b)
Debt / FCF = 8.07 (Net Debt 5.70b / FCF TTM 707.0m)
Total Stockholder Equity = 34.96b (last 4 quarters mean from totalStockholderEquity)
RoA = -39.50% (Net Income -21.28b / Total Assets 42.85b)
RoE = -60.89% (Net Income TTM -21.28b / Total Stockholder Equity 34.96b)
RoCE = -52.72% (EBIT -22.04b / Capital Employed (Equity 34.96b + L.T.Debt 6.84b))
RoIC = -44.86% (negative operating profit) (NOPAT -16.53b / Invested Capital 36.85b)
WACC = 4.24% (E(10.68b)/V(17.65b) * Re(6.51%) + D(6.97b)/V(17.65b) * Rd(1.02%) * (1-Tc(0.25)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈1.05b ; Y1≈690.7m ; Y5≈315.1m
Fair Price DCF = 28.33 (EV 10.04b - Net Debt 5.70b = Equity 4.34b / Shares 153.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -52.19 | EPS CAGR: -2.29% | SUE: -0.07 | # QB: 0
Revenue Correlation: -42.24 | Revenue CAGR: -19.93% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=14.43 | Chg30d=+0.142 | Revisions Net=-1 | Growth EPS=+46.2% | Growth Revenue=+0.0%